Verano Holdings (VRNO) Non Operating Income (2021 - 2026)
Verano Holdings (VRNO) reported Non Operating Income of -$1.2 million for Q1 2026, up 86.67% year-over-year from -$654627.6 in Q1 2025, and up 97.57% quarter-over-quarter from -$50.3 million in Q4 2025.
Verano Holdings (VRNO) Non Operating Income (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$1.2 million, up 86.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$60.2 million (down 395.83% YoY), and the FY2025 annual result was -$59.1 million, down 1449.31% from the prior year.
- Non Operating Income improved to -$1.2 million in Q1 2026 per VRNO's latest filing, from -$50.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $44.6 million in Q4 2024 and troughed at -$50.3 million in Q4 2025.
- A 5-year average of -$1.2 million and a median of -$595000.0 in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 2958.13% in 2022, then slumped 1107.91% in 2025.
- A 5-year view of Non Operating Income shows it stood at $24.3 million in 2022, then slumped by 91.54% to $2.1 million in 2023, then jumped by 2072.5% to $44.6 million in 2024, then tumbled by 212.91% to -$50.3 million in 2025, then surged by 97.57% to -$1.2 million in 2026.
- Business Quant data shows VRNO's Non Operating Income at -$1.2 million in Q1 2026, -$50.3 million in Q4 2025, and -$9.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -50.31 Mn |
| Sep 30, 2025 | -9.89 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | -9.17 Mn |
| Dec 31, 2024 | 44.56 Mn |
| Sep 30, 2024 | -13.86 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Mar 31, 2024 | -759,000.00 |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | -15.81 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 24.25 Mn |
| Sep 30, 2022 | -595,000.00 |
| Jun 30, 2022 | 3.55 Mn |
| Mar 31, 2022 | 2.53 Mn |
| Dec 31, 2021 | 793,000.00 |
| Sep 30, 2021 | 233,000.00 |
| Jun 30, 2021 | -5.99 Mn |